The leukotrienes arise from oxidative metabolism of arachidonic acid t
hrough the action of the 5-lipoxygenase enzyme, leading to the unstabl
e allylic epoxide leukotriene A(4). This intermediate represents the s
ubstrate for two different specific enzymes, namely leukotriene A(4)-h
ydrolase and leukotriene C-4-synthase, generating LTB4 and cysteinyl l
eukotrienes, respectively. The name ''leukotriene'' is referring to th
e cellular source (leukocytes are one of the major sources) as well as
the conjugated triene that characterizes their structure. LTC4 and LT
D4 are potent contracting agents of smooth muscle in airways and blood
vessels; in addition, they induce mucus secretion and promote plasmat
ic exudation with direct action on endothelial cells, On the other sid
e, LTB4 is known as a potent chemokinetic and chemotactic agent, A num
ber of evidences reported in the literature underline the potential ro
le of leukotrienes in the inflammatory responses that characterize ast
hma and other pathological conditions. These potent lipid bioeffectors
are synthesized during the course of inflammatory reactions and their
pharmacological modulation is able to significantly attenuate the cli
nical manifestations associated with different inflammatory pathologie
s.